Provided by Tiger Trade Technology Pte. Ltd.

Artivion

36.60
-4.0500-9.96%
Volume:1.43M
Turnover:52.45M
Market Cap:1.73B
PE:174.29
High:39.07
Open:38.95
Low:33.85
Close:40.65
52wk High:48.25
52wk Low:21.97
Shares:47.37M
Float Shares:41.69M
Volume Ratio:3.58
T/O Rate:3.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2100
EPS(LYR):0.2100
ROE:2.70%
ROA:2.97%
PB:3.87
PE(LYR):174.29

Loading ...

Artivion Earnings Call Highlights Growth, Margin Momentum

TIPRANKS
·
Feb 14

Artivion Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Feb 14

Artivion Falls on 4Q Adjusted Earnings Miss

Dow Jones
·
Feb 14

Artivion Down Nearly 7%, on Pace for Largest Percent Decrease Since February 2025 -- Data Talk

Dow Jones
·
Feb 14

Ladenburg Thalmann & Co. Reaffirms Their Hold Rating on Artivion (AORT)

TIPRANKS
·
Feb 13

Artivion slightly misses Q4 revenue estimates

Reuters
·
Feb 13

BRIEF-Artivion Q4 Revenue USD 115.992 Million Vs. IBES Estimate USD 116.4 Million

Reuters
·
Feb 13

Artivion Outlook FY Adjusted Ebitda Growth 18-22%

THOMSON REUTERS
·
Feb 13

Artivion Q4 Adjusted EPS USD 0.17 VS. Ibes Estimate USD 0.08

THOMSON REUTERS
·
Feb 13

Artivion Q4 EPS USD 0.05

THOMSON REUTERS
·
Feb 13

Artivion Outlook FY Adjusted Ebitda USD 105-110 Million

THOMSON REUTERS
·
Feb 13

Artivion Inc FY2026 REV View $490.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Feb 13

Press Release: Artivion Reports Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Feb 13

Lake Street Sticks to Their Buy Rating for Artivion (AORT)

TIPRANKS
·
Feb 07

Earning Preview: Artivion Q4 revenue is expected to increase by 15.47%, and institutional views are cautiously positive

Earnings Agent
·
Feb 05

Artivion Price Target Maintained With a $58.00/Share by Needham

Dow Jones
·
Feb 03

Artivion: Positive Clinical Data and Pipeline Progress Support Sustained Growth and Buy Rating

TIPRANKS
·
Feb 03

Artivion (AORT) Receives a Buy from Lake Street

TIPRANKS
·
Feb 02

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Artivion (AORT)

TIPRANKS
·
Feb 02

Artivion announces presentations of clinical data from Nexus and AMD trials

TIPRANKS
·
Feb 02